Drug Type Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals |
Synonyms AcuTect, Technetium Tc 99m apcitide, Technetium-99m apcitide + [2] |
Target |
Action antagonists |
Mechanism GP IIb/IIIa antagonists(Integrin alpha-IIb/beta-3 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date United States (14 Sep 1998), |
Regulation- |
Molecular FormulaC51H73N17NaO20S5Tc |
InChIKeyZSGICUWBNPIMTG-AYDXVUFGSA-J |
CAS Registry178959-14-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute deep vein thrombosis of lower limb | United States | 14 Sep 1998 |
Not Applicable | 73 | (Pediatric patients aged 1-6 years) | tailgncdak(wibsgpvtuz) = pdoyunecnr qorzrsganp (vhniekdvke ) View more | Positive | 19 Nov 2018 | ||
(Pediatric patients aged 7-17 years) | tailgncdak(wibsgpvtuz) = uokwljktdq qorzrsganp (vhniekdvke ) View more |